HempFusion Launches Ingestible and Topical CBD Products into Another Top 15 US Supermarket Chain Cannabis Investing News
Aptose Enters into Exclusive Worldwide License Agreement with Hanmi Pharmaceutical for Clinical-Stage Myeloid Kinome Inhibitor HM43239 Market News
INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of BMY, EAR, HYZN, WDH Investors, Lead Plaintiff Deadlines Set Pharmaceutical Investing
BRISTOL MYERS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY Pharmaceutical Investing
Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases Pharmaceutical Investing
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates Pharmaceutical Investing
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, HNST and HYZN Pharmaceutical Investing
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Units Pharmaceutical Investing
